Literature DB >> 23897252

BRAF V600E mutation analysis simplifies the testing algorithm for Lynch syndrome.

Ming Jin1, Heather Hampel, Xiaoping Zhou, Lisa Schunemann, Martha Yearsley, Wendy L Frankel.   

Abstract

OBJECTIVES: To evaluate our experience of adding reflex BRAF mutation analysis following mismatch repair (MMR) protein staining in the test algorithm for Lynch syndrome (LS), the most common inherited predisposition to colorectal cancer (CRC).
METHODS: Since January 1, 2009, BRAF V600E mutation analysis has been performed at our institution for all newly diagnosed CRCs with absent MLH1 and PMS2 proteins.
RESULTS: Ninety (22%) of 412 patients with CRC had at least 1 MMR absent (65 had MLH1 and PMS2 absent and 25 had other stain(s) absent). BRAF mutation was found in 36 (55%) of 65. Fifty-four (13%) of 412 patients required follow-up after addition of BRAF analysis compared with 90 who would have required follow-up without BRAF analysis.
CONCLUSIONS: The addition of reflex BRAF mutation testing in CRCs with absent MLH1 and PMS2 reduced the number of patient contacts by 40% and simplified the genetic testing for LS, leading to cost and time savings.

Entities:  

Keywords:  BRAF mutation; Immunohistochemistry; Lynch syndrome; Microsatellite instability; Mismatch repair genes

Mesh:

Substances:

Year:  2013        PMID: 23897252     DOI: 10.1309/AJCPB9FOVH1HGKFR

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer.

Authors:  Aparna R Parikh; Nancy L Keating; Pang-Hsiang Liu; Stacy W Gray; Carrie N Klabunde; Katherine L Kahn; David A Haggstrom; Sapna Syngal; Benjamin Kim
Journal:  J Oncol Pract       Date:  2016-03       Impact factor: 3.840

2.  Applying public health screening criteria: how does universal newborn screening compare to universal tumor screening for Lynch syndrome in adults with colorectal cancer?

Authors:  Deborah Cragun; Rita D DeBate; Tuya Pal
Journal:  J Genet Couns       Date:  2014-10-18       Impact factor: 2.537

3.  Evaluating utility and feasibility of mismatch repair testing of colorectal cancer patients in a low-middle-income country.

Authors:  Inas Elsayed; Robert Geraghty; Salwa O Mekki; Ahmed A Mohamedani; Susan Ahern; Omer E H Salim; Balgis B M Khalil; Sawsan Abdelrahim; Suliman H Suliman; Moawia M A Elhassan; Salah O Salah; Mohamed E Salih; Abubakr H Widatalla; Osman S Abdelhamed; Xiaosheng Wang; Éanna J Ryan; Des Winter; Salih Bakhiet; Kieran Sheahan
Journal:  Sci Rep       Date:  2022-06-29       Impact factor: 4.996

4.  VE1 immunohistochemistry accurately detects BRAF V600E mutations in colorectal carcinoma and can be utilized in the detection of poorly differentiated colorectal serrated adenocarcinoma.

Authors:  Sara Sajanti; Päivi Sirniö; Juha P Väyrynen; Anne Tuomisto; Kai Klintrup; Jyrki Mäkelä; Ari Ristimäki; Markus J Mäkinen
Journal:  Virchows Arch       Date:  2014-04-11       Impact factor: 4.064

Review 5.  Molecular genetics of microsatellite-unstable colorectal cancer for pathologists.

Authors:  Wei Chen; Benjamin J Swanson; Wendy L Frankel
Journal:  Diagn Pathol       Date:  2017-03-04       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.